Health Trials

Alpha Radiation

1

Review clinical trials related to Alpha Radiation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous SCC for Immunocompromised Patients

This is a multi-center clinical study enrolling up to 28 participants. The primary objectives are to determine the objective response rate (ORR) established by the confirmed best overall response (BOR) following intratumoral administration of DaRT - Diffusing Alpha-Emitters Radiation Therapy. Secondary objectives are to: 1. Determine Progression Free Survival (PFS) up to 12 months after Alpha DaRT sources insertion. 2. Assess Overall Survival (OS) of patients treated with DaRT up to 12 months. 3. Assess Local control up to 12 months after DaRT insertion.

Participants needed: 28
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Alpha Tau Medical LTD.Updated: Jun 16, 2026Locations: 11
Eligibility criteria

1. Patients with cutaneous SCC histologically confirmed 2. Histopathological con... [+8]

1. Distant or nodal metastatic disease (according to the TNM staging system - N+... [+5]

Read more